MyFinsight
Home
Blog
About
Contact
Download
Download image
ILet
$10,089K
(4.79%↑ Y/Y)
Single Use Products
$6,834K
(62.75%↑ Y/Y)
Single Use Products
$10,238K
(209.68%↑ Y/Y)
ILet
$465K
(-8.10%↓ Y/Y)
Comprehensive loss
-$22,394K
(21.37%↑ Y/Y)
Interest income
$2,376K
(-2.46%↓ Y/Y)
Durable Medical
Equipment Channel
$16,923K
(22.39%↑ Y/Y)
Pharmacy Benefit Plan
Channel
$10,703K
(180.77%↑ Y/Y)
Net loss
-$21,895K
(23.59%↑ Y/Y)
Unrealized loss on
short-term and long-term...
-$499K
(-385.14%↓ Y/Y)
Total other income
(expense), net
$2,376K
(123.73%↑ Y/Y)
Net sales
$27,626K
(56.62%↑ Y/Y)
Loss from operations
-$24,271K
(-30.20%↓ Y/Y)
Gross profit
$16,437K
(83.22%↑ Y/Y)
Cost of sales
$11,189K
(29.08%↑ Y/Y)
Total operating
expenses
$40,708K
(47.42%↑ Y/Y)
Sales and marketing
$20,735K
(54.72%↑ Y/Y)
Research and development
$10,356K
(36.44%↑ Y/Y)
General and
administrative
$9,617K
(45.25%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)